Overview
In 2025, the WHO Global Neglected Tropical Diseases
Programme marks 20 years of action and data. Since
its establishment in 2005, a concerted effort involving
pharmaceutical manufacturers, development partners,
philanthropic organizations, national health authorities
and WHO has contributed to a measurable decline in the
global burden of neglected tropical diseases (NTDs).
This report presents progress made in 2023–2024
towards the 2030 targets set in Ending the neglect to
attain the Sustainable Development Goals: a road map
for neglected tropical diseases 2021-2030 (the road map),
including several important analytical updates:
Progress on all overarching, cross-cutting and
disease-specific indicators, milestones and targets.
Analysis of disease burden in terms of disability-adjusted life years (DALYs), prevalence and
mortality, as well as numbers of people affected
by NTDs, detected and treated.
New perspectives on the financial risk associated
with NTDs, highlighting their impoverishing effects
on affected populations.
A detailed review of four thematic areas –
diagnostics, monitoring and evaluation, access
and logistics, and advocacy and funding – enabled
by the Gap Assessment Tool (GAT).
Analysis of official development assistance for
NTDs in the context of a constrained and evolving
financial landscape.